In vitro diagnostic substances, reagents, test kits and sets (6550): United States public contracts since 2024

Updated 17 October 2026 · all lines

In vitro diagnostic substances, reagents, test kits and sets (6550): United States public contracts since 2024. Since January 2024 the line carries 7,757 contracts worth $534,341,793 from 11 agencies. 334 suppliers share it. $229,413,507 in 2024. $201,721,614 in 2025. $103,206,672 in 2026.

Assay record ASY-US-10DFQJB1G9 · Cite as: Assay Systems, “In vitro diagnostic substances, reagents, test kits and sets (6550): United States public contracts since 2024”, https://assay-systems.com/register/us/line/in-vitro-diagnostic-substances/

The line

Since January 2024 the line carries 7,757 contracts worth $534,341,793 from 11 agencies. 334 suppliers share it.

$229,413,507 in 2024. $201,721,614 in 2025. $103,206,672 in 2026.

Suppliers in the line, by value since 2024

The extract for this line

Names every department and buying office behind the figures, who holds each contract now, its value, contract number and end date, the open notices with their closing dates, and the notices behind every figure.

Largest suppliers in the line

Share of the line held by each of its largest suppliers, by value, in the USAspending register.

CEPHEID12.7%BIOMERIEUX INC9.5%ROCHE DIAGNOSTICS CORPORATION8.7%BECKMAN COULTER, INC7.9%ABBOTT LABORATORIES INC.5.7%ATLANTIC TRADING LLC5.0%SYSMEX AMERICA, INC3.5%SIEMENS HEALTHCARE DIAGNOSTICS INC.2.9%ABBOTT MOLECULAR INC.2.7%ILLUMINA, INC.2.5%

All suppliers in United States, A to Z

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.